{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:09:42Z","timestamp":1788487782677,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nutr"],"DOI":"10.1186\/s40795-025-01112-3","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T06:46:56Z","timestamp":1751611616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of zinc supplementation on atherogenic risk indices in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial"],"prefix":"10.1186","volume":"11","author":[{"given":"Farzaneh","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Mohsenpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad Amin","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hassan","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"1112_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jhep.2016.08.024","volume":"66","author":"K Gariani","year":"2017","unstructured":"Gariani K, Ryu D, Menzies KJ, Yi H-S, Stein S, Zhang H, Perino A, Lemos V, Katsyuba E, Jha P. Inhibiting Poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. J Hepatol. 2017;66:132\u201341.","journal-title":"J Hepatol"},{"key":"1112_CR2","doi-asserted-by":"publisher","first-page":"e0240195","DOI":"10.1371\/journal.pone.0240195","volume":"15","author":"MC Kim","year":"2020","unstructured":"Kim MC, Lee JI, Kim JH, Kim HJ, Cho YK, Jeon WK, Kim BI, Sohn W. Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease. PLoS ONE. 2020;15:e0240195.","journal-title":"PLoS ONE"},{"key":"1112_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/liv.13643","volume":"38","author":"AR Ara\u00fajo","year":"2018","unstructured":"Ara\u00fajo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S. Global epidemiology of non-alcoholic fatty liver disease\/non\u2010alcoholic steatohepatitis: what we need in the future. Liver Int. 2018;38:47\u201351.","journal-title":"Liver Int"},{"key":"1112_CR4","first-page":"149","volume":"7","author":"I Moghaddasifar","year":"2016","unstructured":"Moghaddasifar I, Lankarani K, Moosazadeh M, Afshari M, Ghaemi A, Aliramezany M, Gharebagh RA, Malary M. Prevalence of non-alcoholic fatty liver disease and its related factors in Iran. Int J Organ Transplantation Med. 2016;7:149.","journal-title":"Int J Organ Transplantation Med"},{"key":"1112_CR5","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","volume":"42","author":"A Deprince","year":"2020","unstructured":"Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metabolism. 2020;42:101092.","journal-title":"Mol Metabolism"},{"key":"1112_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/hep.28899","volume":"65","author":"JE Kaikkonen","year":"2017","unstructured":"Kaikkonen JE, W\u00fcrtz P, Suomela E, Lehtovirta M, Kangas AJ, Jula A, Mikkil\u00e4 V, Viikari JS, Juonala M, R\u00f6nnemaa T. Metabolic profiling of fatty liver in young and middle-aged adults: cross\u2010sectional and prospective analyses of the young Finns study. Hepatology. 2017;65:491\u2013500.","journal-title":"Hepatology"},{"key":"1112_CR7","first-page":"138","volume":"69","author":"S Koba","year":"2011","unstructured":"Koba S, Hirano T. Dyslipidemia and atherosclerosis. Nihon Rinsho Japanese J Clin Med. 2011;69:138\u201343.","journal-title":"Nihon Rinsho Japanese J Clin Med"},{"key":"1112_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50:285\u201394.","journal-title":"Arch Med Res"},{"key":"1112_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40795-021-00490-8","volume":"7","author":"AA Sangouni","year":"2021","unstructured":"Sangouni AA, Orang Z, Mozaffari-Khosravi H. Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial. BMC Nutr. 2021;7:1\u20137.","journal-title":"BMC Nutr"},{"key":"1112_CR10","doi-asserted-by":"publisher","first-page":"100105","DOI":"10.1016\/j.metop.2021.100105","volume":"11","author":"M Barbara","year":"2021","unstructured":"Barbara M, Mindikoglu AL. The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease. Metabolism Open. 2021;11:100105.","journal-title":"Metabolism Open"},{"key":"1112_CR11","first-page":"1577","volume":"32","author":"R Rafiei","year":"2014","unstructured":"Rafiei R, Sobhani A, Amraee M, Torabi Z, Majlesi M. The relationship between plasma zinc concentration and hepatic encephalopathy in patients with cirrhosis. J Isfahan Med School. 2014;32:1577\u201384.","journal-title":"J Isfahan Med School"},{"key":"1112_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/nu10010088","volume":"10","author":"T Himoto","year":"2018","unstructured":"Himoto T, Masaki T. Associations between zinc deficiency and metabolic abnormalities in patients with chronic liver disease. Nutrients. 2018;10:88.","journal-title":"Nutrients"},{"key":"1112_CR13","doi-asserted-by":"publisher","first-page":"126635","DOI":"10.1016\/j.jtemb.2020.126635","volume":"62","author":"M Fathi","year":"2020","unstructured":"Fathi M, Alavinejad P, Haidari Z, Amani R. The effects of zinc supplementation on metabolic profile and oxidative stress in overweight\/obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. J Trace Elem Med Biol. 2020;62:126635.","journal-title":"J Trace Elem Med Biol"},{"key":"1112_CR14","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.nut.2010.03.007","volume":"26","author":"PJ Little","year":"2010","unstructured":"Little PJ, Bhattacharya R, Moreyra AE, Korichneva IL. Zinc and cardiovascular disease. Nutrition. 2010;26:1050\u20137.","journal-title":"Nutrition"},{"key":"1112_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11684-013-0251-9","volume":"7","author":"X Miao","year":"2013","unstructured":"Miao X, Sun W, Fu Y, Miao L, Cai L. Zinc homeostasis in the metabolic syndrome and diabetes. Front Med. 2013;7:31\u201352.","journal-title":"Front Med"},{"key":"1112_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.biopha.2006.02.004","volume":"60","author":"G Partida-Hern\u00e1ndez","year":"2006","unstructured":"Partida-Hern\u00e1ndez G, Arreola F, Fenton B, Cabeza M, Rom\u00e1n-Ramos R, Revilla-Monsalve M. Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomed Pharmacother. 2006;60:161\u20138.","journal-title":"Biomed Pharmacother"},{"key":"1112_CR17","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2174\/1573401314666180420094522","volume":"15","author":"JS Severo","year":"2019","unstructured":"Severo JS, Morais J, Beserra JB, de Farias LM, dos Santos LR, de Sousa Melo SR. Do nascimento Nogueira N, do nascimento Marreiro D: effect of zinc supplementation on lipid profile in obese people: A systematic review. Curr Nutr Food Sci. 2019;15:551\u20136.","journal-title":"Curr Nutr Food Sci"},{"key":"1112_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12576-017-0571-7","volume":"68","author":"J Olechnowicz","year":"2018","unstructured":"Olechnowicz J, Tinkov A, Skalny A, Suliburska J. Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism. J Physiological Sci. 2018;68:19\u201331.","journal-title":"J Physiological Sci"},{"key":"1112_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.autrev.2014.11.008","volume":"14","author":"P Bonaventura","year":"2015","unstructured":"Bonaventura P, Benedetti G, Albar\u00e8de F, Miossec P. Zinc and its role in immunity and inflammation. Autoimmun Rev. 2015;14:277\u201385.","journal-title":"Autoimmun Rev"},{"key":"1112_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.14310\/horm.2002.1244","volume":"8","author":"M Hashemipour","year":"2009","unstructured":"Hashemipour M, Kelishadi R, Shapouri J, Sarrafzadegan N, Amini M, Tavakoli N, Movahedian-Attar A, Mirmoghtadaee P, Poursafa P. Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children. Hormones. 2009;8:279\u201385.","journal-title":"Hormones"},{"key":"1112_CR21","doi-asserted-by":"publisher","first-page":"174243","DOI":"10.1016\/j.ejphar.2021.174243","volume":"907","author":"AH Faghfouri","year":"2021","unstructured":"Faghfouri AH, Zarezadeh M, Aghapour B, Izadi A, Rostamkhani H, Majnouni A, Abu-Zaid A, Varkaneh HK, Ghoreishi Z, Ostadrahimi A. Clinical efficacy of zinc supplementation in improving antioxidant defense system: A comprehensive systematic review and time-response meta-analysis of controlled clinical trials. Eur J Pharmacol. 2021;907:174243.","journal-title":"Eur J Pharmacol"},{"key":"1112_CR22","first-page":"161","volume":"3","author":"L Payahoo","year":"2013","unstructured":"Payahoo L, Ostadrahimi A, Mobasseri M, Bishak YK, Farrin N, Jafarabadi MA, Mahluji S. Effects of zinc supplementation on the anthropometric measurements, lipid profiles and fasting blood glucose in the healthy obese adults. Adv Pharm Bull. 2013;3:161.","journal-title":"Adv Pharm Bull"},{"key":"1112_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jtemb.2019.05.007","volume":"55","author":"S Asghari","year":"2019","unstructured":"Asghari S, Hosseinzadeh-Attar MJ, Alipoor E, Sehat M, Mohajeri-Tehrani MR. Effects of zinc supplementation on serum adiponectin concentration and glycemic control in patients with type 2 diabetes. J Trace Elem Med Biol. 2019;55:20\u20135.","journal-title":"J Trace Elem Med Biol"},{"key":"1112_CR24","doi-asserted-by":"publisher","first-page":"126659","DOI":"10.1016\/j.jtemb.2020.126659","volume":"63","author":"F Moradi","year":"2021","unstructured":"Moradi F, Kooshki F, Nokhostin F, Khoshbaten M, Bazyar H, Gargari BP. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial. J Trace Elem Med Biol. 2021;63:126659.","journal-title":"J Trace Elem Med Biol"},{"key":"1112_CR25","doi-asserted-by":"publisher","first-page":"127002","DOI":"10.1016\/j.jtemb.2022.127002","volume":"73","author":"H Hern\u00e1ndez-Mendoza","year":"2022","unstructured":"Hern\u00e1ndez-Mendoza H, Mart\u00ednez-Navarro I, Hern\u00e1ndez-Ochoa E, Espinoza-Ruiz M, Lugo-Trampe A, Trujillo-Murillo KdC, L\u00f3pez-Garc\u00eda MA, Rios-Lugo MJ, Chang-Rueda C. Serum zinc levels are associated with obesity and low-density lipoprotein cholesterol in Mexican adults. J Trace Elem Med Biol. 2022;73:127002.","journal-title":"J Trace Elem Med Biol"},{"key":"1112_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-0035-1548790","volume":"123","author":"F Foroozanfard","year":"2015","unstructured":"Foroozanfard F, Jamilian M, Jafari Z, Khassaf A, Hosseini A, Khorammian H, Asemi Z. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes. 2015;123:215\u201320.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1112_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14715\/cmb\/2018.64.11.1","volume":"64","author":"V Cinar","year":"2018","unstructured":"Cinar V, Akbulut T, Kilic Y, Sarikaya M. The effect of 6-week zinc supplement and weight training on the blood lipids of the sedentaries and athletes. Cell Mol Biol. 2018;64:1\u20135.","journal-title":"Cell Mol Biol"},{"key":"1112_CR28","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.numecd.2020.03.021","volume":"30","author":"O Asbaghi","year":"2020","unstructured":"Asbaghi O, Sadeghian M, Fouladvand F, Panahande B, Nasiri M, Khodadost M, Shokri A, Pirouzi A, Sadeghi O. Effects of zinc supplementation on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Nutr Metabolism Cardiovasc Dis. 2020;30:1260\u201371.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"key":"1112_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12011-018-1249-6","volume":"185","author":"A P\u00e9rez","year":"2018","unstructured":"P\u00e9rez A, Rojas P, Carrasco F, Basfi-Fer K, P\u00e9rez-Bravo F, Codoceo J, Inostroza J, Ruz M. Zinc supplementation does not affect glucagon response to intravenous glucose and insulin infusion in patients with well-controlled type 2 diabetes. Biol Trace Elem Res. 2018;185:255\u201361.","journal-title":"Biol Trace Elem Res"},{"key":"1112_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/ajcn\/nqz041","volume":"110","author":"X Wang","year":"2019","unstructured":"Wang X, Wu W, Zheng W, Fang X, Chen L, Rink L, Min J, Wang F. Zinc supplementation improves glycemic control for diabetes prevention and management: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2019;110:76\u201390.","journal-title":"Am J Clin Nutr"},{"key":"1112_CR31","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.1152\/ajpendo.2001.281.1.E25","volume":"281","author":"CJ Lynch","year":"2001","unstructured":"Lynch CJ, Patson BJ, Goodman SA, Trapolsi D, Kimball SR. Zinc stimulates the activity of the insulin-and nutrient-regulated protein kinase mTOR. Am J Physiology-Endocrinology Metabolism. 2001;281:E25\u201334.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"1112_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3109\/09513590.2013.788628","volume":"29","author":"F Grover-P\u00e1ez","year":"2013","unstructured":"Grover-P\u00e1ez F, Zavalza-G\u00f3mez AB, Anaya-Prado R. Raloxifene modifies the insulin sensitivity and lipid profile of postmenopausal insulin resistant women. Gynecol Endocrinol. 2013;29:674\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"1112_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12291-015-0499-8","volume":"31","author":"H Nasrat","year":"2016","unstructured":"Nasrat H, Patra SK, Goswami B, Jain A, Raghunandan C. Study of association of leptin and insulin resistance markers in patients of PCOS. Indian J Clin Biochem. 2016;31:104\u20137.","journal-title":"Indian J Clin Biochem"},{"key":"1112_CR34","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1210\/en.2005-0087","volume":"146","author":"Y Toyoshima","year":"2005","unstructured":"Toyoshima Y, Gavrilova O, Yakar S, Jou W, Pack S, Asghar Z, Wheeler MB, LeRoith D. Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Endocrinology. 2005;146:4024\u201335.","journal-title":"Endocrinology"},{"key":"1112_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1385\/BTER:104:1:041","volume":"104","author":"AK Baltaci","year":"2005","unstructured":"Baltaci AK, Mogulkoc R, Halifeoglu I. Effects of zinc deficiency and supplementation on plasma leptin levels in rats. Biol Trace Elem Res. 2005;104:41\u20136.","journal-title":"Biol Trace Elem Res"},{"key":"1112_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jtemb.2012.08.001","volume":"27","author":"J Capdor","year":"2013","unstructured":"Capdor J, Foster M, Petocz P, Samman S. Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans. J Trace Elem Med Biol. 2013;27:137\u201342.","journal-title":"J Trace Elem Med Biol"},{"key":"1112_CR37","doi-asserted-by":"crossref","unstructured":"Cruz KJC, de Oliveira ARS, do, Nascimento Marreiro D. Antioxidant role of zinc in diabetes mellitus. World journal of diabetes 2015, 6:333.","DOI":"10.4239\/wjd.v6.i2.333"},{"key":"1112_CR38","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3390\/ijerph15122687","volume":"15","author":"S Rivera-Manc\u00eda","year":"2018","unstructured":"Rivera-Manc\u00eda S, Jim\u00e9nez-Osorio AS, Medina-Campos ON, Col\u00edn-Ram\u00edrez E, Vallejo M, Alc\u00e1ntara-Gaspar A, Cartas-Rosado R, Vargas-Barr\u00f3n J, Pedraza-Chaverri J. Activity of antioxidant enzymes and their association with lipid profile in Mexican people without cardiovascular disease: an analysis of interactions. Int J Environ Res Public Health. 2018;15:2687.","journal-title":"Int J Environ Res Public Health"},{"key":"1112_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-018-0932-0","volume":"17","author":"Q Wang","year":"2018","unstructured":"Wang Q, Zheng D, Liu J, Fang L, Li Q. Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study. Lipids Health Dis. 2018;17:1\u20136.","journal-title":"Lipids Health Dis"},{"key":"1112_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12944-020-01319-2","volume":"19","author":"B-y Dong","year":"2020","unstructured":"Dong B-y, Mao Y-q, Li Z-y, Yu F-j. The value of the atherogenic index of plasma in non-obese people with non-alcoholic fatty liver disease: a secondary analysis based on a cross-sectional study. Lipids Health Dis. 2020;19:148.","journal-title":"Lipids Health Dis"}],"container-title":["BMC Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-025-01112-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40795-025-01112-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-025-01112-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T06:46:57Z","timestamp":1751611617000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnutr.biomedcentral.com\/articles\/10.1186\/s40795-025-01112-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1112"],"URL":"https:\/\/doi.org\/10.1186\/s40795-025-01112-3","relation":{},"ISSN":["2055-0928"],"issn-type":[{"value":"2055-0928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"7 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shiraz University of Medical Sciences, Shiraz, Iran (Code: IR.SUMS.REC.1397.105). This study was also performed based on the declaration of Helsinki and good clinical practice guidelines. The informed consent form was completed for all the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}